Argatroban

In the US, Argatroban (argatroban systemic) is a member of the drug class thrombin inhibitors and is used to treat Thrombotic/Thromboembolic Disorder.

US matches:

• Argatroban


• Argatroban Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AE03

CAS registry number (Chemical Abstracts Service)

0074863-84-6

Chemical Formula

C23-H36-N6-O5-S

Molecular Weight

508

Therapeutic Category

Anticoagulant agent: Direct thrombin inhibitor

Chemical Name

(2R,4R)-4-Methyl-1-[(S)-N²-[[(RS)-1,2,3,4-tetrahydro-3-methyl-8-quinolyl]sulfonyl]arginyl]pipecolic acid

Foreign Names

• Argatrobanum (Latin)
• Argatroban (German)
• Argatroban (French)
• Argatroban (Spanish)

Generic Names

• Argatroban (OS: JAN, USAN, BAN)
• Argipidine (IS)
• MQPA (IS)
• DK 7419 (IS)
• GN 1600 (IS)
• MCI 9038 (IS: Mitsubishi)
• MD 805 (IS: Mitsubishi)
• OM 805 (IS)

Brand Names

• Arganova
  Mitsubishi, Netherlands



• Argaron
  Nichi-Iko PharmaceuticalJMA, Japan



• Argatra
  Mitsubishi, Austria; Mitsubishi, Germany



• Argatroban
  Encysive, United States



• Gartban
  Shiono Kemikaru, Japan



• Novastan
  Biovitrum, Sweden; Italchimici, Italy; Mitsubishi, China; Mitsubishi, Norway; Mitsubishi Pharma Europe Ltd., Denmark; Tanabe Mitsubishi, Japan



• Novastan HI
  Tanabe Mitsubishi, Japan



• Argatroban
  GlaxoSmithKline, United States



• Slonnon Hi
  Daiichi Sankyo, Japan



• Slovastan
  Sawai Seiyaku, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.